Literature DB >> 9547419

Off-treatment fatigue in breast cancer survivors: a controlled comparison.

M A Andrykowski1, S L Curran, R Lightner.   

Abstract

Fatigue is a common and distressing symptom following cancer treatment. Research examining "off-treatment" fatigue has been weakened by limited assessments of fatigue and lack of suitable comparison groups. The extent of off-treatment fatigue following treatment for breast cancer (BC) was examined. Women with BC (n = 88; mean, 28 months posttreatment) and age-matched women (n = 88) with benign breast problems (BBP), completed a set of fatigue questionnaires at an Initial assessment and a 4-month Follow-up assessment. The BC group reported more fatigue, more weakness, and less vitality relative to the BBP group at both assessments. No relationship was found in the BC group between fatigue and extent of treatment or time since treatment completion. While the results document the existence of off-treatment fatigue following BC, elucidation of the psychobiological processes underlying this symptom and development of clinical management strategies remain as challenges for future research.

Entities:  

Mesh:

Year:  1998        PMID: 9547419     DOI: 10.1023/a:1018700303959

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  44 in total

1.  Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients.

Authors:  G Berglund; C Bolund; T Fornander; L E Rutqvist; P O Sjödén
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer.

Authors:  E Bruera; C Brenneis; M Michaud; J Rafter; A Magnan; A Tennant; J Hanson; R N Macdonald
Journal:  J Pain Symptom Manage       Date:  1989-06       Impact factor: 3.612

3.  Energy: a crucial consideration in the nursng process.

Authors:  M B Ryden
Journal:  Nurs Forum       Date:  1977

4.  Answering autobiographical questions: the impact of memory and inference on surveys.

Authors:  N M Bradburn; L J Rips; S K Shevell
Journal:  Science       Date:  1987-04-10       Impact factor: 47.728

5.  Patients and radiotherapy. 3. Patients' experiences after discharge.

Authors:  A Eardley
Journal:  Radiography       Date:  1986 Jan-Feb

6.  Fatigue in the cancer patient: a conceptual approach to a clinical problem.

Authors:  J Aistars
Journal:  Oncol Nurs Forum       Date:  1987 Nov-Dec       Impact factor: 2.172

Review 7.  Why women gain weight with adjuvant chemotherapy for breast cancer.

Authors:  W Demark-Wahnefried; E P Winer; B K Rimer
Journal:  J Clin Oncol       Date:  1993-07       Impact factor: 44.544

8.  Psychosocial problems among survivors of Hodgkin's disease.

Authors:  P Fobair; R T Hoppe; J Bloom; R Cox; A Varghese; D Spiegel
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

9.  The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals.

Authors:  D Irvine; L Vincent; J E Graydon; N Bubela; L Thompson
Journal:  Cancer Nurs       Date:  1994-10       Impact factor: 2.592

10.  Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer.

Authors:  M T Knobf
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

View more
  59 in total

1.  A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Authors:  Glenn J Lesser; Doug Case; Nancy Stark; Susan Williford; Jeff Giguere; L Astrid Garino; Michelle J Naughton; Mara Z Vitolins; Mark O Lively; Edward G Shaw
Journal:  J Support Oncol       Date:  2013-03

Review 2.  Sleep disturbance, inflammation and depression risk in cancer survivors.

Authors:  Michael R Irwin; Richard E Olmstead; Patricia A Ganz; Reina Haque
Journal:  Brain Behav Immun       Date:  2012-05-24       Impact factor: 7.217

Review 3.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

4.  Cancer-related fatigue and associated disability in post-treatment cancer survivors.

Authors:  Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell
Journal:  J Cancer Surviv       Date:  2015-04-16       Impact factor: 4.442

5.  Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population.

Authors:  Inger Schou; Øivind Ekeberg; Leif Sandvik; Marianne J Hjermstad; Cornelia M Ruland
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

6.  Ecological momentary assessment of fatigue following breast cancer treatment.

Authors:  Shelly L Curran; Abbie O Beacham; Michael A Andrykowski
Journal:  J Behav Med       Date:  2004-10

7.  A comparison of disrupted sleep patterns in women with cancer-related fatigue and postmenopausal women without cancer.

Authors:  Horng-Shiuann Wu; Jean E Davis; Josna P Padiyar; Hossein Yarandi
Journal:  Eur J Oncol Nurs       Date:  2010-11-18       Impact factor: 2.398

Review 8.  Cancer-related fatigue: links with inflammation in cancer patients and survivors.

Authors:  Julienne E Bower
Journal:  Brain Behav Immun       Date:  2007-05-31       Impact factor: 7.217

9.  Factors predicting fatigue in breast cancer patients.

Authors:  Shahpar Haghighat; Mohammad Esmail Akbari; Kourosh Holakouei; Abbas Rahimi; Ali Montazeri
Journal:  Support Care Cancer       Date:  2003-05-03       Impact factor: 3.603

Review 10.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.